ADMA BIOLOGICS, INC. — Investor Relations & Filings
Filings indexed
962
across all filing types
Latest filing
2024-02-21
Regulatory Filings
Country
US
United States of America
Listing
US
ADMA
ADMA Biologics, Inc. is an end-to-end commercial biopharmaceutical company that develops, manufactures, and commercializes specialty plasma-derived biologics. The company's portfolio features FDA-approved immune globulin (Ig) products for the treatment of immune-compromised patients and individuals at risk for certain infections. ADMA Biologics operates a vertically integrated manufacturing process for its specialty biologic products and utilizes a patented immunotechnology platform, which includes a proprietary microneutralization assay to measure neutralizing antibody levels in plasma. The company also offers contract manufacturing capabilities.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2024-02-21 | English | |
| SC 13G/A | 2024-02-14 | English | |
| Major Shareholding Notification 2024 | 2024-02-14 | English | |
| Major Shareholding Notification 2024 | 2024-02-14 | English | |
| Major Shareholding Notification 2024 | 2024-02-14 | English | |
| SCHEDULE 13G | 2024-02-13 | English |
Browse filings by year
21 years- 2026 26 filings
- 2025 65 filings
- 2024 85 filings
- 2023 56 filings
- 2022 57 filings
- 2021 74 filings
- 2020 76 filings
- 2019 75 filings
- 2018 66 filings
- 2017 86 filings
- 2016 34 filings
- 2015 55 filings
- 2014 49 filings
- 2013 52 filings
- 2012 79 filings
- 2011 4 filings
- 2010 4 filings
- 2009 4 filings
- 2008 4 filings
- 2007 4 filings
- 2006 7 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
11 filings
| |||||
| 12003784 | 8-K | 2024-02-21 | English | ||
| 12003786 | SC 13G/A | 2024-02-14 | English | ||
| 12003787 | Major Shareholding Notification 2024 | 2024-02-14 | English | ||
| 12003788 | Major Shareholding Notification 2024 | 2024-02-14 | English | ||
| 12003794 | Major Shareholding Notification 2024 | 2024-02-14 | English | ||
| 12003795 | SCHEDULE 13G | 2024-02-13 | English | ||
| 12003796 | Major Shareholding Notification 2024 | 2024-01-26 | English | ||
| 12003793 | 8-K | 2024-01-08 | English | ||
| 12003799 | 8-K | 2024-01-08 | English | ||
| 12003800 | FORM 4 | 2024-01-06 | English | ||
| 12003801 | Director's Dealing 2024 | 2024-01-06 | English | ||
|
2023
4 filings
| |||||
| 12003804 | 8-K | 2023-12-18 | English | ||
| 12003807 | 8-K | 2023-12-12 | English | ||
| 12003809 | 8-K | 2023-11-16 | English | ||
| 12003811 | 10-Q | 2023-11-08 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
ADMA BIOLOGICS, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31261/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31261 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31261 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31261 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31261}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ADMA BIOLOGICS, INC. (id: 31261)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.